Table 3.
Laboratory results of the included COVID-19 patients after two sequential negative nucleic acid testing with repeated analyses after 3–5 days
| Total | Moderate | Mild | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | After negative | 3–5 days after negative | P | N | After negative | 3–5 days after negative | P | N | After negative | 3–5 days after negative | P | |
| WBC count, ×109 /L | 20 | 7.7 (4.7, 10.2) | 6.37 (5.1, 7.65) | 0.080 | 13 | 7.7 (4.8, 10.2) | 6.83 (5.04, 7.74) | 0.126 | 7 | 7.7 (4.3, 10.4) | 6.33 (5.05, 6.92) | 0.310 |
| Neutrophile granulocyte, % | 18 | 53.3 (50, 62.5) | 52.7 (45.4, 57.6) | 0.064 | 12 | 55.2 (49, 65.5) | 53.3 (43.7, 60.7) | 0.099 | 6 | 52.8 (45.9, 61.1) | 50.2 (43.7, 54.2) | 0.463 |
| Lymphocyte count, ×109 /L | 15 | 2.11 (1.65, 2.82) | 2.21 (1.66, 2.58) | 0.609 | 10 | 1.99 (1.52, 2.86) | 2.11 (1.51, 2.55) | 0.721 | 5 | 2.11 (1.9, 4.21) | 2.28 (1.76, 3.11) | 0.893 |
| Lymphocyte, % | 20 | 34.6 (29.6, 46.1) | 34.9 (29.8, 44) | 0.904 | 13 | 32.3 (26, 39.5) | 34.4 (28.5, 42.5) | 0.272 | 7 | 39.9 (30.5, 52) | 35.4 (31.9, 45.1) | 0.310 |
| C-reactive protein, mg/L | 9 | 1.92 (1.02, 3.54) | 0.87 (0.43, 2.13) | 0.123 | 5 | 2.35 (1.15, 15.19) | 1.24 (0.32, 3.73) | 0.500 | 4 | 1.2 (0.97, 2.54) | 0.75 (0.41, 0.91) | 0.109 |